Press Releases
Genzyme’s Alemtuzumab Shows Sustained Reduction in Relapses and Disability...
Genzyme Corporation reported five-year patient data from its completed Phase 2 multiple sclerosis (MS) trial. This sub-group analysis found that nearly 90 percent of alemtuzumab-treated...
Press Releases
Weight Watchers and Merck Collaborate to Help Physicians Fight...
NEW YORK, NY and Whitehouse Station, NJ (October 13, 2010) – Weight Watchers International, Inc., the world's leading provider of weight management services, and Merck,...
Press Releases
Pfizer to Acquire King Pharmaceuticals, Inc.
Pfizer Inc.and King Pharmaceuticals, Inc. announced that they have entered into a definitive merger agreement. Under the terms of the agreement, Pfizer will acquire King,...
Press Releases
ImmunoGen, Inc. Announces Positive Interim Results in Randomized Clinical...
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products, today announced the reporting of positive interim clinical data with trastuzumab-DM1 (T-DM1) for first-line...
Press Releases
AJ Precision Components to Exhibit at Interplas 2011
AJ Precision Components will be exhibiting at Interplas 2011 from 27 to 29 September. Come and visit us on stand A58 in hall 4...
Press Releases
APR and Labtec enter into exclusive License Agreement with...
APR and its development partner Labtec have entered into an exclusive licensing agreement with the leading European pharmaceutical company Ferrer Internacional (Ferrer) for the promotion,...
Press Releases
Baxter Receives Approval For PREFLUCEL Seasonal Influenza Vaccine In...
Baxter International Inc. announced the first approval of PREFLUCEL by the Austrian Agency for Health and Food Safety (AGES). The vaccine was shown to be...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.